Kristine Ashcraft

ORCID: 0000-0002-6609-0075

Pharmacology, Toxicology and PharmaceuticsMedicineEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology”.

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology

Journal of Clinical Oncology(2024)10.1200/jco.23.01748

N/A

0.524DataRank · unranked

32 citations

Devon Adams, Brittany A. McKelvey, Jeannine S. McCune, Dale Miles, Victoria M. Pratt +5 more

Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program

Journal of Personalized Medicine(2022)10.3390/jpm12020161

N/A

0DataRank · unranked

5 citations

Rachel Dalton, Nicolas Moyer, Meghan J. Arwood, Khoa A. Nguyen, Jill M. Sumfest +3 more